Summary by Futu AI
On July 25, 2024, a significant reorganization took place affecting the ownership structure of HOOKIPA Pharma Inc. Invus Global Management, LLC became the managing member of Invus Public Equities Advisors, LLC, resulting in a shift in beneficial ownership of HOOKIPA Pharma's common stock. Invus Public Equities, L.P. now directly holds 566,640 shares, representing 5.9% of the company, with Invus Public Equities Advisors, LLC, Invus Global Management, LLC, Siren, L.L.C., and Mr. Raymond Debbane potentially deemed to beneficially own these shares due to their respective control relationships. This change follows the exit of the Artal Parties, including Artal International, Artal International Management, Artal Group, Westend, Stichting Administratiekantoor Westend, and Mr. Amaury Wittouck, who are no longer considered beneficial owners of the shares previously held by Invus Public Equities. The reorganization was reported in a Schedule 13G filing with the SEC, reflecting the updated ownership status immediately following the event.